Currently the only widely used forms of contraception available to men are condoms and vasectomies. There’s a substantial potential market for other methods. A 2018 study in Lancet Global Health found that almost half of all pregnancies in the US and worldwide are unintended. Another study, published in 2024 in the journal Contraception, placed the potential US market for new male contraceptives at 7 million to 15.5 million men. And an earlier assessment of the global market, from 2016 in Springer Nature, estimated it at anywhere from $40 billion to $200 billion.